日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201

一项针对 II/III 期直肠癌的辅助治疗方案(FOLFIRI、FOLFOX 或 5-FU/亚叶酸钙)的多中心随机 III 期研究:ECOG-ACRIN E3201

Kam, Audrey E; Zhao, Fengmin; Meropol, Neal J; Giantonio, Bruce J; Diasio, Robert B; Flynn, Patrick J; Catalano, Paul; Hartner, Lee; Rowland, Kendrith M; Song, Wei; Mulcahy, Mary F; Sinicrope, Frank A; Whitehead, Robert P; Mayer, Robert J; Petrelli, Nicholas; O'Dwyer, Peter J; Hamilton, Stanley R; Cella, David; Benson, Al B

Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology])

早期乳腺癌蒽环类药物试验的长期随访(USOR 06-090、NSABP B-46-I/USOR 07132 和 NSABP B-49 [NRG Oncology])

Geyer, Charles E Jr; Blum, Joanne L; Yothers, Greg; Asmar, Lina; Flynn, Patrick J; Robert, Nicholas J; Hopkins, Judith O; O'Shaughnessy, Joyce A; Rastogi, Priya; Puhalla, Shannon L; Hilton, Christie J; Dang, Chau T; Gómez, Henry Leonidas; Vukelja, Svetislava J; Lyss, Alan P; Paul, Devchand; Brufsky, Adam M; Colangelo, Linda H; Swain, Sandra M; Mamounas, Eleftherios P; Wolmark, Norman

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11

一项评估芳香化酶抑制剂肌肉骨骼症状遗传预测因子的队列研究:ECOG-ACRIN E1Z11 研究结果

Stearns, Vered; Jegede, Opeyemi A; Chang, Victor T-S; Skaar, Todd C; Berenberg, Jeffrey L; Nand, Ranveer; Shafqat, Atif; Jacobs, Nisha L; Luginbuhl, William; Gilman, Paul; Benson, Al B 3rd; Goodman, Judie R; Buchschacher, Gary L Jr; Henry, N Lynn; Loprinzi, Charles L; Flynn, Patrick J; Mitchell, Edith P; Fisch, Michael J; Sparano, Joseph A; Wagner, Lynne I

Unit cohesion during deployment and post-deployment mental health: is cohesion an individual- or unit-level buffer for combat-exposed soldiers?

部署期间的部队凝聚力和部署后的心理健康:对于经历过战斗的士兵来说,凝聚力是个人层面的缓冲还是部队层面的缓冲?

Campbell-Sills, Laura; Flynn, Patrick J; Choi, Karmel W; Ng, Tsz Hin H; Aliaga, Pablo A; Broshek, Catherine; Jain, Sonia; Kessler, Ronald C; Stein, Murray B; Ursano, Robert J; Bliese, Paul D

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

CODEL:一项针对新诊断的1p/19q共缺失少突胶质细胞瘤的放疗、放疗联合替莫唑胺或替莫唑胺单药治疗的III期研究。基于初始研究设计的分析

Jaeckle, Kurt A; Ballman, Karla V; van den Bent, Martin; Giannini, Caterina; Galanis, Evanthia; Brown, Paul D; Jenkins, Robert B; Cairncross, J Gregory; Wick, Wolfgang; Weller, Michael; Aldape, Kenneth D; Dixon, Jesse G; Anderson, S Keith; Cerhan, Jane H; Wefel, Jeffrey S; Klein, Martin; Grossman, Stuart A; Schiff, David; Raizer, Jeffrey J; Dhermain, Frederick; Nordstrom, Donald G; Flynn, Patrick J; Vogelbaum, Michael A

NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab

NRG Oncology/NSABP B-47 月经史研究:辅助化疗联合或不联合曲妥珠单抗的影响

Ganz, Patricia A; Cecchini, Reena S; Fehrenbacher, Louis; Geyer, Charles E Jr; Rastogi, Priya; Crown, John P; Thirlwell, Michael P; Ellison, David M; Boileau, Jean-Francois; Flynn, Patrick J; Jeong, Jong-Hyeon; Mamounas, Eleftherios P; Wolmark, Norman

A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer

一项针对胰腺癌切除患者的 GI-4000(一种表达突变 RAS 蛋白的重组酵母)的 II 期随机安慰剂对照辅助治疗试验

Muscarella, Peter; Bekaii-Saab, Tanios; McIntyre, Kristi; Rosemurgy, Alexander; Ross, Sharona B; Richards, Donald A; Fisher, William E; Flynn, Patrick J; Mattson, Alicia; Coeshott, Claire; Roder, Heinrich; Roder, Joanna; Harrell, Frank E; Cohn, Allen; Rodell, Timothy C; Apelian, David

NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2

NSABP B-47/NRG肿瘤学III期随机试验比较了FISH检测HER2阴性且IHC 1+或2级的高危浸润性乳腺癌患者接受辅助化疗联合或不联合曲妥珠单抗治疗的效果。

Fehrenbacher, Louis; Cecchini, Reena S; Geyer, Charles E Jr; Rastogi, Priya; Costantino, Joseph P; Atkins, James N; Crown, John P; Polikoff, Jonathan; Boileau, Jean-Francois; Provencher, Louise; Stokoe, Christopher; Moore, Timothy D; Robidoux, André; Flynn, Patrick J; Borges, Virginia F; Albain, Kathy S; Swain, Sandra M; Paik, Soonmyung; Mamounas, Eleftherios P; Wolmark, Norman

An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer

一项针对进展期和转移性甲状腺球蛋白抗体阴性放射性碘难治性分化型甲状腺癌的帕唑帕尼国际II期研究

Bible, Keith C; Menefee, Michael E; Lin, Chia-Chi Josh; Millward, Michael J; Maples, William J; Goh, Boon Cher; Karlin, Nina J; Kane, Madeleine A; Adkins, Douglas R; Molina, Julian R; Donehower, Ross C; Lim, Wan-Teck; Flynn, Patrick J; Richardson, Ronald L; Traynor, Anne M; Rubin, Joseph; LoRusso, Patricia M; Smallridge, Robert C; Burton, Jill K; Suman, Vera J; Kumar, Aditi; Voss, Jessie S; Rumilla, Kandalaria M; Kipp, Benjamin R; Chintakuntlawar, Ashish V; Harris, Pamela; Erlichman, Charles

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)

一项针对接受术前放化疗的 II 期或 III 期直肠癌患者的术后奥沙利铂、5-氟尿嘧啶和亚叶酸钙与奥沙利铂、5-氟尿嘧啶、亚叶酸钙和贝伐珠单抗的组间随机 III 期研究:ECOG-ACRIN 研究组的一项试验 (E5204)

Chakravarthy, A Bapsi; Zhao, Fengmin; Meropol, Neal J; Flynn, Patrick J; Wagner, Lynne I; Sloan, Jeffrey; Diasio, Robert B; Mitchell, Edith P; Catalano, Paul; Giantonio, Bruce J; Catalano, Robert B; Haller, Daniel G; Awan, Rashid A; Mulcahy, Mary F; O'Brien, Timothy E; Santala, Roger; Cripps, Christine; Weis, John R; Atkins, James N; Leichman, Cynthia G; Petrelli, Nicholas J; Sinicrope, Frank A; Brierley, James D; Tepper, Joel E; O'Dwyer, Peter J; Sigurdson, Elin R; Hamilton, Stanley R; Cella, David; Benson, Al B 3rd